Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,159Revenue $M25.1Net Margin (%)-774.1Altman Z-Score-9.1
Enterprise Value $M1,420EPS $-1.4Operating Margin %-615.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-774.7Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales39.05-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-59.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M196ROIC % (ttm)-156.6Gross Margin Increase y-yN

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELFirst Eagle Investment 2014-06-30 Sold Out $3.22 - $3.8
($3.45)
$ 5.9171%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 5.91-14%Reduce 65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 5.9112%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 5.9115%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 5.9118%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 5.91-19%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out $7.22 - $12.45
($9.89)
$ 5.91-40%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 5.914%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.86)
$ 5.91-14%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 5.915%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.88)
$ 5.9121%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 5.9123%Reduce 25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARCHESI VINCENT TDirector 2014-09-17Buy20,000$1.71245.61 view
WILLSEY LANCEDirector 2013-08-29Buy10,000$5.1514.76 view
MARCHESI VINCENT TDirector 2012-12-20Buy4,000$4.6826.28 view
MARCHESI VINCENT TDirector 2012-12-19Buy6,000$4.7225.21 view
Schwab GiselaEVP and Chief Medical Officer 2012-12-10Buy25,000$4.3934.62 view
MARCHESI VINCENT TDirector 2012-06-14Sell7,000$5.1315.2 view
RIVERA LUPE MEVP, Operations 2010-12-17Sell29,427$8.5-30.47 view
RIVERA LUPE MEVP, Operations 2010-12-15Sell75,000$7.5-21.2 view
Schwab GiselaEVP & Chief Medical Officer 2010-12-09Sell4,112$6.5-9.08 view
WILLSEY LANCEDirector 2010-09-07Buy36,200$3.664.17 view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 25 2010 
Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 
Exelixis Announces Second Quarter 2009 Financial Results Jul 30 2009 

More From Other Websites
What to Expect from Exelixis (EXEL) This Earnings Season? (revised) - Analyst Blog Jul 29 2015
Can the Rally in Exelixis (EXEL) Shares Continue? - Tale of the Tape Jul 29 2015
Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015 Jul 28 2015
Exelixis to Release Second Quarter 2015 Financial Results on Tuesday, August 11, 2015 Jul 28 2015
What to Expect from Exelixis (EXEL) This Earnings Season? - Analyst Blog Jul 28 2015
Exelixis (EXEL) Stock Falls on Upsized Secondary Offering Jul 27 2015
EXELIXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 24 2015
How to Trade 4 of the Market's Most Active Stocks Jul 24 2015
Exelixis Prices Public Offering of Common Stock Jul 23 2015
Exelixis Prices Public Offering of Common Stock Jul 23 2015
The Zacks Analyst Blog Highlights: Amgen, Exelixis, Regeneron, Five Prime Therapeutics and AbbVie -... Jul 23 2015
Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on Positive Data -... Jul 22 2015
Exelixis (EXEL) Stock Declines on Secondary Public Offering Jul 22 2015
Exelixis Meteoric Rise on Positive Kidney Cancer Study Data - Analyst Blog Jul 21 2015
How Exelixis Used Good News to Raise Over $100 Million in New Capital Jul 21 2015
Exelixis Launches Proposed Public Offering of Common Stock Jul 21 2015
Exelixis Launches Proposed Public Offering of Common Stock Jul 21 2015
EXELIXIS, INC. Files SEC form 8-K, Other Events Jul 20 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK